How big is Editas Medicine, Inc.?

Jun 22 2025 06:07 PM IST
share
Share Via
As of Jun 18, Editas Medicine, Inc. has a market capitalization of 179.15 million and reported net sales of 35.83 million, with a net profit loss of 251.24 million. Shareholder's funds are 134.27 million, and total assets amount to 341.59 million.
As of Jun 18, Editas Medicine, Inc. has a market capitalization of 179.15 million, categorizing it as a Micro Cap company.
As of Jun 18, the company reported net sales of 35.83 million for the latest four quarters. However, it also experienced a net profit loss of 251.24 million during the same period. As of Dec 24, the reporting period shows that Editas Medicine, Inc. has shareholder's funds amounting to 134.27 million and total assets of 341.59 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News